Travere Therapeutics, Inc. (TVTX)
55.70
-1.97
(-3.42%)
USD |
NASDAQ |
Oct 06, 14:48
Travere Therapeutics Max Drawdown (5Y) : 83.44% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 83.44% |
| August 31, 2026 | 83.44% |
| July 31, 2026 | 83.44% |
| June 30, 2026 | 83.44% |
| May 31, 2026 | 83.44% |
| April 30, 2026 | 83.44% |
| March 31, 2026 | 83.44% |
| February 28, 2026 | 83.44% |
| January 31, 2026 | 83.44% |
| December 31, 2025 | 83.44% |
| November 30, 2025 | 83.44% |
| October 31, 2025 | 83.44% |
| September 30, 2025 | 83.44% |
| August 31, 2025 | 83.44% |
| July 31, 2025 | 83.44% |
| June 30, 2025 | 83.44% |
| May 31, 2025 | 83.44% |
| April 30, 2025 | 83.44% |
| March 31, 2025 | 83.44% |
| February 28, 2025 | 83.44% |
| January 31, 2025 | 83.44% |
| December 31, 2024 | 83.44% |
| November 30, 2024 | 83.44% |
| October 31, 2024 | 83.44% |
| September 30, 2024 | 83.44% |
| Date | Value |
|---|---|
| August 31, 2024 | 83.44% |
| July 31, 2024 | 83.44% |
| June 30, 2024 | 83.44% |
| May 31, 2024 | 83.44% |
| April 30, 2024 | 83.44% |
| March 31, 2024 | 82.88% |
| February 29, 2024 | 82.88% |
| January 31, 2024 | 82.88% |
| December 31, 2023 | 82.88% |
| November 30, 2023 | 82.88% |
| October 31, 2023 | 79.60% |
| September 30, 2023 | 75.95% |
| August 31, 2023 | 72.49% |
| July 31, 2023 | 72.49% |
| June 30, 2023 | 72.49% |
| May 31, 2023 | 72.49% |
| April 30, 2023 | 72.49% |
| March 31, 2023 | 72.49% |
| February 28, 2023 | 72.49% |
| January 31, 2023 | 72.49% |
| December 31, 2022 | 72.49% |
| November 30, 2022 | 72.49% |
| October 31, 2022 | 72.49% |
| September 30, 2022 | 72.49% |
| August 31, 2022 | 72.49% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| BioMarin Pharmaceutical, Inc. | 58.73% |
| TG Therapeutics, Inc. | 93.19% |
| Krystal Biotech, Inc. | 53.42% |
| RenovoRx, Inc. | 96.25% |
| Pelthos Therapeutics, Inc. | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 4.280 |
| Beta (5Y) | 1.134 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 67.13% |
| Historical Sharpe Ratio (5Y) | 0.2328 |
| Historical Sortino (5Y) | 0.4574 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.88% |